Does AXICABTAGENE CILOLEUCEL Cause Disease progression? 745 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 745 reports of Disease progression have been filed in association with AXICABTAGENE CILOLEUCEL (YESCARTA). This represents 8.7% of all adverse event reports for AXICABTAGENE CILOLEUCEL.
745
Reports of Disease progression with AXICABTAGENE CILOLEUCEL
8.7%
of all AXICABTAGENE CILOLEUCEL reports
326
Deaths
137
Hospitalizations
How Dangerous Is Disease progression From AXICABTAGENE CILOLEUCEL?
Of the 745 reports, 326 (43.8%) resulted in death, 137 (18.4%) required hospitalization, and 31 (4.2%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for AXICABTAGENE CILOLEUCEL.
What Other Side Effects Does AXICABTAGENE CILOLEUCEL Cause?
Cytokine release syndrome (4,140)
Immune effector cell-associated neurotoxicity syndrome (1,821)
Neurotoxicity (1,327)
Pyrexia (859)
Death (756)
Hypotension (398)
Neutropenia (391)
Confusional state (299)
Encephalopathy (292)
Diffuse large b-cell lymphoma (291)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which AXICABTAGENE CILOLEUCEL Alternatives Have Lower Disease progression Risk?
AXICABTAGENE CILOLEUCEL vs AXITINIB
AXICABTAGENE CILOLEUCEL vs AZACITIDINE
AXICABTAGENE CILOLEUCEL vs AZATHIOPRINE
AXICABTAGENE CILOLEUCEL vs AZD-1222
AXICABTAGENE CILOLEUCEL vs AZELAIC ACID